Macrophage colony-stimulating factor antagonists inhibit replication of HIV-1 in human macrophages

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4955-4960

  Kutza, Joseph ^a,b   Crim, Lynne ^b   Feldman, Steven ^b   Hayes, Mark P ^c   Gruber, Marion ^b   Beeler, Judy ^b   Clouse, Kathleen A ^b  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR ANTAGONIST; CYTOKINE ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS LOAD; VIRUS REPLICATION;

EID: 0034194262     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4955     Document Type: Article

References (36)

1. Unanue, E. R. 1989. Macrophages, antigen presenting cells, and the phenomena of antigen handling and presentation. In Fundamental Immunology. W. E. Paul, ed. Raven Press, New York, pp. 95-115.
2. Lewis, C. E., and J. O. McGee, eds. 1992. The Macrophage. IRL Press at Oxford University Press, New York.
3. Joseph, B. S., P. W. Lampert, and M. B. Oldstone. 1975. Replication and persistence of measles virus in defined subpopulations of human leukocytes. J. Virol. 16:1638.
4. Vydelingum, S., K. Suryanarayana, R. G. Marusyk, and A. A. Salmi. 1995. Replication of measles virus in human monocytes and T cells. Clin. J. Microbiol. 41:620.
5. Midulla, F., Y. T. Huang, I. A. Gilbert, N. M. Cirino, E. R. McFadden, and J. R. Panuska. 1989. Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages. Am. Rev. Respir. Dis. 140:771.
6. Kimpen, J. L. 1996. Respiratory syncytial virus immunology. Pediatr. Allergy Immunol. 7:86.
7. Krilov, L. R., R. M. Hendry, E. Godfrey, and K. McIntosh. 1987. Respiratory virus infection of peripheral blood monocytes: correlation with aging of cells and interferon production in vitro. J. Gen. Virol. 68:1749.
8. Meltzer, M. S., and H. E. Gendelman. 1992. Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease. In Macrophage Biology and Activation. S. W. Russell and S. Gordon, eds. Springer-Verlag, New York, pp. 239-263
9. Potts, B. J., W. Maury, and M. A. Martin. 1990. Replication of HIV-1 in primary monocyte cultures. Virology 175:465.
10. Karp, C. L., M. Wysocka, L. M. Wahl, J. M. Aheam, P. J. Cuomo, B. Sherry, G. Trinchieri, and D. E. Griffin. 1996. Mechanisms of suppression ot cell-mediated immunity by measles virus. Science 273:228.
11. Wahl, S. M., J. M. Orenstein, and P. D. Smith. 1996. Macrophage functions in HIV-1 infection. In Immunology of HIV infection. S. Gupta, ed. Plenum Press, New York, pp. 303-335.
12. Gruber, M. F., K. A. Weih, E. J. Boone, P. D. Smith, and K. A. Clouse. 1995. Endogenous macrophage CSF production is associated with viral replication in HIV-1 infected human monocyte-derived macrophages. J. Immunol. 154:5528.
13. Kalter, D. C., M. Nakamura, J. A. Turpin, L. M. Baca, D. L. Hoover, C. Diefenbach, P. Ralph, H. E. Gendelman, and M. S. Meltzer. 1991. Enhanced HIV replication in macrophage colony stimulating factor trealed monocytes. J. Immunol. 146:298.
14. Bergamini, A., C. F. Perno, L. Dini, L. Falasca, G. Milanese, R. Calio, and G. Rocchi. 1994. Macrophage colony stimulating factor enhances the susceptibility of macrophages to infection by human immunodeficiency virus and reduced the activity of compounds that inhibit virus binding. Blood 84:3405.
15. Wang, J., G. Roderiquez, T. Oravec, and M. A. Norcross. 1998. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J. Virol. 9:7642.
16. Gerrard, T. L., C. H. Jurgensen, and A. S. Fauci. 1983. Differential effect of monoclonal anti-DR antibody on monocytes in antigen and mitogen stimulated responses: mechanism of inhibition and relationship to interleukin-1 secretion. Cell. Immunol. 82:394.
17. Gendelman, H. E., J. M. Orenstein. L. M. Baca, B. Weiser, H. Burger, D. C. Kalter, and M. S. Meltzer. 1989. The macrophage in the persistence of and pathogenesis of HIV-1 infection. AIDS 3:475.
18. Gendelman, H. E., J. M. Orenstein, M. A. Martin, C. Ferruca, R. Mitra, T. Phipps, L. A. Wahl, H. C. Lane, A. S. Fauci, and D. S. Burke. 1988. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony stimulating factor 1 treated monocytes. J. Exp. Med. 167:1428.
19. Hoffman, A. D. 1985. Characterization of the AIDS associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326.
20. Hsiung, G. D. 1994. Virus assay, neutralization test and antiviral assay. In Diagnostic Virology: As Illustrated by Light and Electron Microscopy. G. D. Hsiung, ed. Yale University Press, New Haven, pp. 46-54.
21. Nakoinz, I. M., T. Lee, J. F. Weaver, and P. Randolph. 1990. Differentiation of the IL-3 dependent NFS-60 cell line and adaptation to growth in macrophage colony stimulating factor. J. Immunol. 145:860.
22. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55.
23. Stanley, E. R., K. L. Berg, D. B. Einstein, P. S. Lee, and Y. G. Yeung. 1994. The biology and action of colony stimulating factor-1. Stem Cells 12:15.
24. Stanley, E. R., K. L Berg, D. B. Einstein, P. S. Lee, F. J. Pixley, Y. Wang, and Y. G. Yeung. 1997. Biology and action of colony stimulating factor-1. Mol. Reprod. Dev. 46:4.
25. Gallo, P., A. DeRossi, S. Sivieri, L. Chieco-Bianchi, and B. Tavolata. 1994. M-CSF production by HIV-1 and its intrathecal synthesis. J Neuroimmunol. 51:193.
26. Meltzer, M. S., M. Nakamura, B. D. Hansen, J. A. Turpin, D. C. Kalter, and H. E. Gendelman. 1990. Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res. Hum. Retroviruses 6:967.
27. Canque, B., M. Rozenwajg, A. Gey, E. Tartour, W. H. Fridman, and J. C. Gluckman. 1996. Macrophage inflammatory protein-1α is induced by human immunodeficiency virus infection of monocyte derived macrophages. Blood 87:2100.
28. Schmidtmayerova, H., H. S. Nottet, G. Nuovo, T. Raabe, C. R. Flanagan, L. Dubrovsky, H. E. Gendelman, A. Cerami, M. Bukrinsky, and B. Sherry. 1996. Human immunodeficiency virus type 1 infection alters chemokine β peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA 93:700.
29. Fahey, T. J., P. Tekamp-Olson, L. S. Cousens, W. G. Jones, G. T. Shires, A. Cerami, and B. Sherry. 1992. Macrophage inflammatory protein 1α modulates macrophage function. J. Immunol. 148:2764.
30. Schall, T. J., K. Bacon, R. Camp, J. W. Kaspari, and D.V. Goeddel. 1993. Human macrophage inflammatory protein 1α (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177:1821.
31. Broder, C. C., and R. G. Collman. 1997. Chemokine receptors and HIV. J. Leukocyte Biol. 62:20.
32. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. DiMarzio, S. Marmon, R. E. Sutton, C. M. Hill, et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661.
33. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 181:667.
34. Swingler, S., A. Mann, J. M. Jacque, B. Brichacek, V. G. Sasseville, K. Williams, A. A. Lackner, E. N. Janoff, R. Wang, D. Fisher, and M. Stevenson. 1999. HIV-1 nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med. 5:997.
35. Chun, T. W., and A. S. Fauci. 1999. Latent reservoirs of HIV: obstacles to the eradication of virus. Proc. Natl. Acad. Sci. USA 96:10958.
36. + T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat. Med. 5:651.